BUMP: TR & Guggenheim Strong Buy ratings hold https://www.tipranks.com/stocks/axgt/price-target https://dakotafinancialnews.com/2020/07/14/axovant-gene-therapies-nasdaqaxgt-receives-market-perform-rating-from-guggenheim.html Interest is maintaining, with chatter on social media as well.